542650 Stoklara Genel Bakış Metropolis Healthcare Limited, Hindistan'da ve uluslararası alanda teşhis hizmetleri sunmaktadır. Daha fazla detay
Ödüller Risk Analizi Risk kontrollerimizden 542650 için herhangi bir risk tespit edilmedi.
Tüm Risk Kontrollerini Gör Düşüncelerinizi, bağlantılarınızı ve şirket anlatımınızı yakalayın
Metropolis Healthcare Limited Rakipler Fiyat Geçmişi ve Performans
Hisse fiyatlarındaki yükseliş, düşüş ve değişimlerin özeti Metropolis Healthcare Tarihsel hisse senedi fiyatları Güncel Hisse Fiyatı ₹1,992.80 52 Haftanın En Yüksek Seviyesi ₹2,306.85 52 Haftanın En Düşük Seviyesi ₹1,450.05 Beta 0.34 1 Aylık Değişim -6.70% 3 Aylık Değişim -9.23% 1 Yıllık Değişim 19.07% 3 Yıllık Değişim -39.07% 5 Yıllık Değişim 22.80% Halka arzdan bu yana değişim 107.68%
Son Haberler & Güncellemeler Metropolis Healthcare Limited (NSEI:METROPOLIS) agreed to acquire Core Diagnostics Private Limited from Core Diagnostics (Mauritius) Private Limited for INR 2.46 billion. Dec 10
Metropolis Healthcare Limited Announces Management Changes Nov 28
Second quarter 2025 earnings: EPS misses analyst expectations Nov 09
Metropolis Healthcare Limited Appoints Aditya Shinde as Interim Chief Financial Officer, Effective November 11, 2024 Nov 08
Metropolis Healthcare Limited to Report Q2, 2025 Results on Nov 08, 2024 Oct 31 Metropolis Healthcare Limited Announces Resignation of Rakesh Agarwal as Chief Financial Officer, Effective November 10, 2024 Oct 12
Daha fazla güncelleme görün Metropolis Healthcare Limited (NSEI:METROPOLIS) agreed to acquire Core Diagnostics Private Limited from Core Diagnostics (Mauritius) Private Limited for INR 2.46 billion. Dec 10
Metropolis Healthcare Limited Announces Management Changes Nov 28
Second quarter 2025 earnings: EPS misses analyst expectations Nov 09
Metropolis Healthcare Limited Appoints Aditya Shinde as Interim Chief Financial Officer, Effective November 11, 2024 Nov 08
Metropolis Healthcare Limited to Report Q2, 2025 Results on Nov 08, 2024 Oct 31 Metropolis Healthcare Limited Announces Resignation of Rakesh Agarwal as Chief Financial Officer, Effective November 10, 2024 Oct 12
Metropolis Healthcare Limited Appoints Pinakin Shah as Chief Information Officer Sep 07 Metropolis Healthcare Limited Announces Changes in Board
Founder & Chairman Emeritus recently sold ₹136m worth of stock Aug 22
Metropolis Healthcare Limited to Report Q1, 2025 Results on Aug 10, 2024 Aug 05
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 02 Metropolis Healthcare Limited, Annual General Meeting, Aug 21, 2024
Metropolis Healthcare Limited, Annual General Meeting, Aug 21, 2024 Jul 29
Founder & Chairman Emeritus recently sold ₹51m worth of stock Jun 13
Price target increased by 7.4% to ₹1,861 Jun 08
Metropolis Healthcare Limited Appoints Sushil Shah as Chairman Emeritus, Effective May 22, 2024 May 23
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind May 22
Metropolis Healthcare Limited to Report Q4, 2024 Results on May 21, 2024 May 16
Founder & Executive Chairman recently sold ₹62m worth of stock Apr 03
Third quarter 2024 earnings: EPS misses analyst expectations Feb 05
Metropolis Healthcare Limited Announces Management Changes Feb 02
Metropolis Healthcare Limited to Report Q3, 2024 Results on Feb 02, 2024 Jan 27
Upcoming dividend of ₹4.00 per share at 0.5% yield Nov 10
Price target increased by 7.4% to ₹1,528 Nov 07
Second quarter 2024 earnings: EPS misses analyst expectations Nov 07
Metropolis Healthcare Limited to Report Q2, 2024 Results on Nov 04, 2023 Oct 29
Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023 Sep 07
Metropolis Healthcare Limited to Report Q1, 2024 Results on Aug 02, 2023 Jul 28
Full year 2023 earnings: EPS and revenues miss analyst expectations Jul 26
Metropolis Healthcare Limited, Annual General Meeting, Aug 17, 2023 Jul 24
Metropolis Healthcare Limited Appoints Neha Shah as Interim Company Secretary Jun 22
Insufficient new directors Jun 01
Price target decreased by 7.5% to ₹1,397 May 19
Full year 2023 earnings: EPS and revenues miss analyst expectations May 17
Metropolis Healthcare Limited to Report Q4, 2023 Results on May 16, 2023 May 11
Upcoming dividend of ₹8.00 per share at 0.6% yield Feb 16
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Feb 12
Metropolis Healthcare Limited Declares Interim Dividend for the Financial Year 2022-23 Feb 11
Metropolis Healthcare Limited to Report Q3, 2023 Results on Feb 10, 2023 Feb 04
Second quarter 2023 earnings: EPS misses analyst expectations Nov 10
Metropolis Healthcare Limited to Report Q2, 2023 Results on Nov 08, 2022 Nov 02
Metropolis Healthcare Limited Announces Resignation of Vijender Singh as Chief Execution Officer Aug 19
Metropolis Healthcare Limited Proposes to Confirm the Payment of Interim Dividend for the Financial Year Ended March 31, 2022 Aug 18
Price target decreased to ₹1,746 Aug 14
Metropolis Healthcare Limited to Report Q1, 2023 Results on Aug 10, 2022 Aug 04
Metropolis Healthcare Limited Announces Resignation of Chief Executive Officer, Effective November 30, 2022 Jul 30
Full year 2022 earnings: EPS and revenues miss analyst expectations Jul 28
Metropolis Healthcare Limited, Annual General Meeting, Aug 17, 2022 Jul 22
Metropolis Healthcare Limited to Report Q4, 2022 Final Results on Jul 18, 2022 Jul 13
GSK Velu Reportedly in Talks with Investors, PEs & Banking Firms to Buy Back Metropolis Healthcare Jun 15 Metropolis Confirms Promoters Have No Intention to Exit the Business
Adani, Apollo Reportedly Explore Bids for Majority Stake in Metropolis Jun 07
Price target decreased to ₹2,461 May 26
Full year 2022 earnings: EPS and revenues miss analyst expectations May 26
Amazon, Flipkart Reportedly in Talks to Buy Stake in Metropolis Healthcare May 21
Metropolis Healthcare Limited to Report Q4, 2022 Results on May 24, 2022 May 17
Investor sentiment improved over the past week Apr 05
Founder & Executive Chairman recently bought ₹100m worth of stock Feb 23
Investor sentiment deteriorated over the past week Feb 18
Upcoming dividend of ₹8.00 per share Feb 14
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Feb 13
Metropolis Healthcare Limited Declares Payment of an Interim Dividend Feb 12
Metropolis Healthcare Limited to Report Q3, 2022 Results on Feb 11, 2022 Feb 04
Investor sentiment deteriorated over the past week Jan 24
Insider recently sold ₹820k worth of stock Jan 01
Price target increased to ₹2,998 Dec 01
Founder & Executive Chairman recently sold ₹1.3b worth of stock Nov 18
Second quarter 2022 earnings released: EPS ₹11.39 (vs ₹11.88 in 2Q 2021) Nov 11
High number of new directors Oct 31
Key Executive recently sold ₹4.8m worth of stock Sep 14
Insider recently sold ₹1.7m worth of stock Sep 04
Price target increased to ₹2,789 Aug 09
Full year 2021 earnings released: EPS ₹35.97 (vs ₹25.36 in FY 2020) Jul 20
Suburban Diagnostics Reportedly in Sale Talks with Dr. Lal PathLabs, Metropolis, Pharmeasy, Others Jun 18
Company Secretary & Compliance Officer Poonam Tanwani has left the company Jun 04
Insider recently sold ₹7.8m worth of stock Jun 03
Price target increased to ₹2,466 May 31
Full year 2021 earnings released: EPS ₹35.97 (vs ₹25.36 in FY 2020) May 30
Chief Executive Officer recently sold ₹5.2m worth of stock Mar 31
Insider recently sold ₹999k worth of stock Mar 23
Chief Executive Officer recently sold ₹109m worth of stock Feb 24
Third quarter 2021 earnings released: EPS ₹11.50 (vs ₹8.38 in 3Q 2020) Feb 12
Revenue and earnings miss expectations Feb 12
Metropolis Healthcare Limited Revises Constitution of the Nomination and Remuneration Committee, with Effect from February 10, 2021 Feb 11
Metropolis Healthcare Limited to Report Q3, 2021 Results on Feb 10, 2021 Feb 05
Price target raised to ₹2,193 Jan 19
Metropolis Healthcare Limited (NSEI:METROPOLIS) agreed to acquire Dr. Ganesan's Hitech Diagnostic Centre Private Limited from Ganesan Subramanian, Manimegalai Ganesan and Malini Parasuraman for INR 6.2 billion. Jan 19
Insider recently sold ₹2.7m worth of stock Jan 08
Insider recently sold ₹2.0m worth of stock Dec 12
Insider recently sold ₹2.0m worth of stock Nov 21
New 90-day high: ₹2,040 Nov 18
Price target raised to ₹2,034 Nov 14
Second quarter 2021 earnings released: EPS ₹11.88 Nov 14
Revenue and earnings beat expectations Nov 14
Metropolis Healthcare Limited (NSEI:METROPOLIS) completed the acquisition of remaining 49% stake in Raj Metropolis Healthcare Private Limited. Nov 06 Hissedar Getirileri 542650 IN Healthcare IN Pazar 7D -3.2% 2.7% 1.6% 1Y 19.1% 37.7% 17.5%
Hissedar getirilerinin tamamını görün
Getiri vs. Endüstri: 542650 geçen yıl % 37.7 oranında getiri sağlayan Indian Healthcare sektörünün gerisinde kaldı.
Getiri vs Piyasa: 542650 geçen yıl % 17.5 oranında getiri sağlayan Indian Piyasasını aştı.
Fiyat Oynaklığı Is 542650's price volatile compared to industry and market? 542650 volatility 542650 Average Weekly Movement 3.8% Healthcare Industry Average Movement 5.2% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.1%
İstikrarlı Hisse Senedi Fiyatı: 542650 son 3 ayda önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: 542650 'nin haftalık oynaklığı ( 4% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında Metropolis Healthcare Limited, Hindistan'da ve uluslararası alanda teşhis hizmetleri sunmaktadır. Şirket klinik laboratuvar testleri ve profil hizmetleri sunmaktadır. Ayrıca onkoloji, nöroloji, jinekoloji ve nefroloji için teşhis hizmetlerinin yanı sıra erkekler, kadınlar, yaşlılar, gençler ve şirketler için çeşitli sağlık kontrol paketleri sunmaktadır.
Daha fazla göster Metropolis Healthcare Limited Temel Bilgiler Özeti Metropolis Healthcare'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır? 542650 temel i̇stati̇sti̇kler Piyasa değeri ₹102.42b Kazançlar(TTM ) ₹1.48b Gelir(TTM ) ₹12.85b
Kazanç ve Gelir En son kazanç raporundan temel karlılık istatistikleri (TTM) 542650 gelir tablosu (TTM ) Gelir ₹12.85b Gelir Maliyeti ₹2.84b Brüt Kâr ₹10.01b Diğer Giderler ₹8.53b Kazançlar ₹1.48b
Temettüler
0.2% Mevcut Temettü Verimi
Şirket Analizi ve Finansal Veri Durumu Veri Son Güncelleme (UTC saati) Şirket Analizi 2025/01/05 08:08 Gün Sonu Hisse Fiyatı 2025/01/03 00:00 Kazançlar 2024/09/30 Yıllık Kazançlar 2024/03/31
Veri Kaynakları Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC 'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
Paket Veri Zaman Çerçevesi Örnek ABD Kaynağı * Şirket Finansalları 10 yıl Gelir tablosu Nakit akış tablosu Bilanço Analist Konsensüs Tahminleri +3 yıl Finansal tahminler Analist fiyat hedefleri Piyasa Fiyatları 30 yıl Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler Sahiplik 10 yıl En büyük hissedarlar İçeriden öğrenenlerin ticareti Yönetim 10 yıl Liderlik ekibi Yönetim Kurulu Önemli Gelişmeler 10 yıl
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube' da eğitimlerimiz bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.
Analist Kaynakları Metropolis Healthcare Limited 33 Bu analistlerden 17, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
Analist Kurum Prashant Nair Ambit Capital null null Antique Stockbroking Ltd. Harith Ahamed Avendus Spark
Göster 30 daha fazla analist 
